Evaluation of Immune System Components in Dogs With Protein-Losing Enteropathy Compared to Healthy Controls
Journal of Veterinary Internal Medicine · 2025
DOI: 10.1111/jvim.70245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2025. Verfasst von Emily Moore und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA. Hauptthemen laut MEDLINE: Dog Diseases, Protein-Losing Enteropathies, Immunoglobulins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: U.S. Department of Agriculture (USDA), National Institute of Food and Agriculture (NIFA).
Abstract (Originalsprache)
Background
Immune system abnormalities including hypogammaglobulinemia and T-cell deficiency occur in humans with protein-losing enteropathy (PLE). It is unknown whether similar abnormalities occur in dogs with PLE.
Objective
To evaluate serum immunoglobulin (Ig) concentrations and immune cell populations in dogs with PLE (with histologic evidence of chronic inflammatory enteropathy, intestinal lymphangiectasia (IL), or both) compared to healthy controls (HC). Animals Eighteen dogs with PLE and 18 HC dogs.
Methods
Prospective study. Serum IgA, IgG, and IgM concentrations were measured via ELISA in treatment-naïve dogs with PLE and compared to concentrations in HC dogs. RNA gene expression of specific immune cell surface markers in peripheral blood mononuclear cells (PBMCs) was measured in both groups by quantitative PCR.
Results
Dogs with PLE had lower concentrations of serum IgG compared to HC dogs (4.5 mg/mL, range 0.67–22.4 mg/mL vs. 19 mg/mL, range 1.8–80.3 mg/mL; p < 0.001). Serum IgM concentrations were also lower in dogs with PLE versus HC (2.4 mg/mL, range 0.0009–53.1 mg/mL vs. 14.2 mg/mL, range 2.1–172.8 mg/mL; p = 0.002). Expression of CD3e (0.24, range 0.003–1.1 vs. 0.92, range 0.41–3.2; p < 0.001), CD5 (0.17, range 0.01–0.46 vs. 0.94, range 0.23–5; p < 0.001), and CD8 (0.47, range 0.06–1.7 vs. 0.92, range 0.32–2.4; p = 0.007) were reduced in dogs with PLE compared to their mean absolute expression in HC dogs. Conclusions and Clinical Importance Dogs with PLE have quantitative reductions in immune system components, similar to humans with IL. These abnormalities in immune system components might be considered in the management and monitoring of dogs with PLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA.
ORCID-Profile: Sara A Jablonski
Förderung
- U.S. Department of Agriculture (USDA)
- National Institute of Food and Agriculture (NIFA)
Zitieren
APA
Moore, E., Thelen Strong, K., & Jablonski, S. A. (2025). Evaluation of Immune System Components in Dogs With Protein-Losing Enteropathy Compared to Healthy Controls. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.70245
Vancouver
Moore E, Thelen Strong K, Jablonski SA. Evaluation of Immune System Components in Dogs With Protein-Losing Enteropathy Compared to Healthy Controls. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.70245
BibTeX
@article{Moore2025,
author = {Moore, Emily and Thelen Strong, Kyan and Jablonski, Sara A},
title = {Evaluation of Immune System Components in Dogs With Protein-Losing Enteropathy Compared to Healthy Controls},
journal = {Journal of Veterinary Internal Medicine},
year = {2025},
doi = {10.1111/jvim.70245}
}
EUVIMED